Literature DB >> 3145862

Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance.

J A Reguera1, F Baquero, J C Perez-Diaz, J L Martinez.   

Abstract

The effect of inoculum size and gene dosage on the level of antibiotic resistance mediated by TEM-1 beta-lactamase was measured. From the results it seemed that gene dosage is a more efficient mechanism than inoculum size for increasing TEM-1 mediated resistance to beta-lactam antibiotics. It also seemed that the two mechanisms for enhancing antibiotic resistance are synergistic. The clinical implications of these results are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145862     DOI: 10.1007/bf01975047

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

1.  Synergistic resistance mechanisms in Pseudomonas aeruginosa.

Authors:  C W Stratton; F Tausk
Journal:  J Antimicrob Chemother       Date:  1987-04       Impact factor: 5.790

2.  Bacterial inoculum and the activity of antimicrobial agents.

Authors:  D E Fry; R N Garrison; L Trachtenberg; H C Polk
Journal:  Surg Gynecol Obstet       Date:  1985-02

Review 3.  Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.

Authors:  J H Nayler
Journal:  J Antimicrob Chemother       Date:  1987-06       Impact factor: 5.790

4.  Amoxycillin/clavulanate resistant Escherichia coli.

Authors:  H Williams; A King; K Shannon; I Phillips
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

Review 5.  Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria.

Authors:  T J Foster
Journal:  Microbiol Rev       Date:  1983-09

6.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

7.  beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies.

Authors:  F Baquero; M F Vicente; J C Pérez-Diaz
Journal:  J Antimicrob Chemother       Date:  1985-02       Impact factor: 5.790

8.  beta-Lactamases and beta-lactam resistance in Escherichia coli.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

  8 in total
  8 in total

Review 1.  Mutation frequencies and antibiotic resistance.

Authors:  J L Martinez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Diversification of Escherichia coli expressing an SHV-type extended-spectrum beta-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins.

Authors:  A Pałucha; B Mikiewicz; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

3.  Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.

Authors:  Carolina Alvarez-Ortega; Irith Wiegand; Jorge Olivares; Robert E W Hancock; José Luis Martínez
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

4.  Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.

Authors:  P J Wu; K Shannon; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

5.  Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.

Authors:  P Stapleton; P J Wu; A King; K Shannon; G French; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

Review 6.  Non-canonical mechanisms of antibiotic resistance.

Authors:  J L Martínez; J Blázquez; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

Review 7.  Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; D McTavish
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 8.  Phenotypic Resistance to Antibiotics.

Authors:  Fernando Corona; Jose L Martinez
Journal:  Antibiotics (Basel)       Date:  2013-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.